Jefferies downgraded Healthcare Realty Trust (HR) to Hold from Buy with a price target of $17, down from $19. The company is entering 2025 with a leadership change, limited external growth potential, and elevated dividend cut risk, the analyst tells investors in a research note. The firm says Healthcare Realty dismissed its former CEO in November and messaged that it would take 6-9 months to appoint a new, permanent CEO. This comes as the company is unable to grow externally given its high leverage and cost of equity, and with a dividend that may take multiple quarters to cover, contends Jefferies. As such, it sees “a lot of uncertainty.”
Don't Miss Our New Year's Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HR:
- Healthcare Realty Trust downgraded to Neutral from Overweight at JPMorgan
- Healthcare Realty Trust price target raised to $17 from $16 at Wells Fargo
- Healthcare Realty Trust announces CFO, general counsel changes
- Healthcare Realty Trust Announces Key Leadership Changes
- Healthcare Realty Trust Revamps Board for Strategic Growth
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
